5 completed, 1 enrolling by invitation, 1 not yet recruiting, 1 terminated. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 2 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Neuraceq: new trials by email Literature Review of Neuraceq trials Research Report on Neuraceq
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging ¹⁸F-florbetaben - Monoclonal Gammopathy, Monoclonal Gammopathy of Undetermined Significance (MGUS) | Not applicable | Not yet recruiting | University of Zurich | 50 | 2026-10-01 | 2026-06-03 |
| Alzheimer's Disease Neuroimaging Initiative 4 Neuraceq, Amyvid, Tauvid - Mild Cognitive Impairment, Alzheimer Disease | Enrolling by invitation | University of Southern California | 1500 | 2023-06-09 | 2026-09-29 | |
| Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis [18F]florbetaben - Cardiac Amyloidosis, AL Amyloidosis | Phase 3 | Completed | Lantheus Germany GmbH | 244 | 2023-01-13 | 2026-10-26 |
| Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease 11C-ER176, [F-18]MK-6240, Florbetaben - Alzheimer Disease, Dementia | Completed | Jose Gutierrez, MD, MPH | 238 | 2020-09-18 | 2024-07-16 | |
| Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT FNOS, Florbetaben - Cardiac Amyloidosis | Early Phase 1 | Terminated | University of Pennsylvania | 3 | 2019-10-01 | 2024-11-12 |
| Biomarkers in Neurodegenerative Diseases Neuraceq - Mild Cognitive Impairment (MCI), Alzheimer Disease (AD) | Withdrawn | University of Minnesota | 2019-10-01 | 2019-11-12 | ||
| Imaging Inflammation in Alzheimer's Disease With 11C-ER176 11C-ER176, Florbetaben - Alzheimer Disease | Phase 1 / Phase 2 | Completed | Columbia University | 9 | 2018-09-10 | 2025-04-17 |
| Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography [18F]Florbetaben - Multiple Myeloma | Not applicable | Completed | Ulsan University Hospital | 14 | 2018-08-20 | 2019-04-18 |
| Imaging Inflammation in Alzheimer's Disease 11C-PBR28, 18F-Florbetaben, Lumbar puncture (optional) - Alzheimer's Disease | Phase 2 | Completed | Patrick Lao | 60 | 2016-06-01 | 2025-03-05 |
Alzheimer Disease (5) · Cognitive Dysfunction (3) · Amyloid Neuropathies, Familial (2) · Dementia (2) · Immunoglobulin Light-chain Amyloidosis (2) · Inflammation (2) · Multiple Myeloma (2) · Amyloidosis (1) · Amyotrophic Lateral Sclerosis (1) · Cognition Disorders (1) · Epilepsy, Temporal Lobe (1) · Frontotemporal Lobar Degeneration (1) · Lewy Body Disease (1) · Monoclonal Gammopathy of Undetermined Significance (1) · Motor Neuron Disease (1)
Columbia University (1) · Jose Gutierrez, MD, MPH (1) · Lantheus Germany GmbH (1) · Patrick Lao (1) · Ulsan University Hospital (1) · University of Minnesota (1) · University of Pennsylvania (1) · University of Southern California (1) · University of Zurich (1)
United States (7) · Canada (1) · Germany (1) · South Korea (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Andrew Stephens, MD, PhD (1) · Dominik C Benz, PD Dr. med. (1) · Jae-Cheol Jo, PhD (1) · Jose Gutierrez, MD, MPH (1) · Keith Vossel, MD, MSc (1) · Michael Weiner, MD (1) · Paco Bravo (1) · Patrick J Lao (1) · Patrick Lao, PhD (1) · Paul Aisen, MD (1) · Ronald Petersen, MD, PHD (1)
K23AG052633 (1), U19AG024904 (1)